Phase 1b study of kinase inhibitor Vactosertib + POM in RRMM. Pharmacologic blockade of TGF beta signaling. Bone marrow -stem cell treatment.
Keywords: Color, Line with Color, Editorial, Publishing, Professional Education, Cell biology / Histology, Molecular Biology, Pharmacology, Oncology, Mechanism of Action (MOA)
© Beth Halasz
